Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer

被引:4
作者
Conces, Madison L. [1 ]
Mahipal, Amit [1 ]
机构
[1] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
关键词
rectal cancer; neoadjuvant therapy; chemotherapy; TOTAL MESORECTAL EXCISION; SHORT-COURSE RADIOTHERAPY; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; COURSE PREOPERATIVE RADIOTHERAPY; CLINICAL COMPLETE RESPONDERS; MEDIAN FOLLOW-UP; QUALITY-OF-LIFE; COLORECTAL-CANCER; INTERNATIONAL WATCH; SEXUAL DYSFUNCTION;
D O I
10.3390/curroncol31010024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Local and metastatic recurrence are primary concerns following the treatment of locally advanced rectal cancer (LARC). Chemoradiation (CRT) can reduce the local recurrence rates and has subsequently moved to the neoadjuvant setting from the adjuvant setting. Pathological complete response (pCR) rates have also been noted to be greater in patients treated with neoadjuvant CRT prior to surgery. The standard approach to treating LARC would often involve CRT followed by surgery and optional adjuvant chemotherapy and remained the treatment paradigm for almost two decades. However, patients were often unable to complete adjuvant chemotherapy due to a decreased tolerance of chemotherapy following surgery, which led to upfront treatment with both CRT and chemotherapy, and total neoadjuvant therapy, or TNT, was created. The efficacy outcomes of local recurrence, disease-free survival, and pCR have improved in patients receiving TNT compared to the standard approach. Additionally, more recent data suggest a possible improvement in overall survival as well. Patients with a complete clinical response following TNT have the opportunity for watch-and-wait surveillance, allowing some patients to undergo organ preservation. Here, we discuss the clinical trials and studies that led to the adoption of TNT as the standard of care for LARC, with the possibility of watch-and-wait surveillance for patients achieving complete responses. We also review the possibility of overtreating some patients with LARC.
引用
收藏
页码:366 / 382
页数:17
相关论文
共 106 条
[41]   Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging-Defined, Locally Advanced Rectal Cancer: Grupo Cancer de Recto 3 Study [J].
Fernandez-Martos, Carlos ;
Pericay, Carles ;
Aparicio, Jorge ;
Salud, Antonieta ;
Safont, MariaJose ;
Massuti, Bertomeu ;
Vera, Ruth ;
Escudero, Pilar ;
Maurel, Joan ;
Marcuello, Eugenio ;
Luis Mengual, Jose ;
Saigi, Eugenio ;
Estevan, Rafael ;
Mira, Moises ;
Polo, Sonia ;
Hernandez, Ana ;
Gallen, Manuel ;
Arias, Fernando ;
Serra, Javier ;
Alonso, Vicente .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) :859-865
[42]   POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01 [J].
FISHER, B ;
WOLMARK, N ;
ROCKETTE, H ;
REDMOND, C ;
DEUTSCH, M ;
WICKERHAM, DL ;
FISHER, ER ;
CAPLAN, R ;
JONES, J ;
LERNER, H ;
GORDON, P ;
FELDMAN, M ;
CRUZ, A ;
LEGAULTPOISSON, S ;
WEXLER, M ;
LAWRENCE, W ;
ROBIDOUX, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01) :21-29
[43]   Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial [J].
Fokas, Emmanouil ;
Schlenska-Lange, Anke ;
Polat, Buelent ;
Klautke, Gunther ;
Grabenbauer, Gerhard G. ;
Fietkau, Rainer ;
Kuhnt, Thomas ;
Staib, Ludger ;
Brunner, Thomas ;
Grosu, Anca-Ligia ;
Kirste, Simon ;
Jacobasch, Lutz ;
Allgaeuer, Michael ;
Flentje, Michael ;
Germer, Christoph-Thomas ;
Gruetzmann, Robert ;
Hildebrandt, Guido ;
Schwarzbach, Matthias ;
Bechstein, Wolf O. ;
Suelberg, Heiko ;
Friede, Tim ;
Gaedcke, Jochen ;
Ghadimi, Michael ;
Hofheinz, Ralf-Dieter ;
Roedel, Claus .
JAMA ONCOLOGY, 2022, 8 (01)
[44]  
Fokas Emmanouil, 2019, J Clin Oncol, V37, P3212, DOI 10.1200/JCO.19.00308
[45]   Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate [J].
Folkesson, J ;
Birgisson, H ;
Pahlman, L ;
Cedermark, B ;
Glimelius, B ;
Gunnarsson, U .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5644-5650
[46]   PREOPERATIVE OR POSTOPERATIVE IRRADIATION IN ADENOCARCINOMA OF THE RECTUM - FINAL TREATMENT RESULTS OF A RANDOMIZED TRIAL AND AN EVALUATION OF LATE SECONDARY EFFECTS [J].
FRYKHOLM, GJ ;
GLIMELIUS, B ;
PAHLMAN, L .
DISEASES OF THE COLON & RECTUM, 1993, 36 (06) :564-572
[47]   Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy [J].
Garcia-Aguilar, Julio ;
Patil, Sujata ;
Gollub, Marc J. ;
Kim, Jin K. ;
Yuval, Jonathan B. ;
Thompson, Hannah M. ;
Verheij, Floris S. ;
Omer, Dana M. ;
Lee, Meghan ;
Dunne, Richard F. ;
Marcet, Jorge ;
Cataldo, Peter ;
Polite, Blase ;
Herzig, Daniel O. ;
Liska, David ;
Oommen, Samuel ;
Friel, Charles M. ;
Ternent, Charles ;
Coveler, Andrew L. ;
Hunt, Steven ;
Gregory, Anita ;
Varma, Madhulika G. ;
Bello, Brian L. ;
Carmichael, Joseph C. ;
Krauss, John ;
Gleisner, Ana ;
Paty, Philip B. ;
Weiser, Martin R. ;
Nash, Garrett M. ;
Pappou, Emmanouil ;
Guillem, Jose G. ;
Temple, Larissa ;
Wei, Iris H. ;
Widmar, Maria ;
Lin, Sabrina ;
Segal, Neil H. ;
Cercek, Andrea ;
Yaeger, Rona ;
Smith, J. Joshua ;
Goodman, Karyn A. ;
Wu, Abraham J. ;
Saltz, Leonard B. .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) :2546-+
[48]   Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3 randomised controlled trial [J].
Gerard, Jean-Pierre ;
Barbet, Nicolas ;
Schiappa, Renaud ;
Magne, Nicolas ;
Martel, Isabelle ;
Mineur, Laurent ;
Deberne, Melanie ;
Zilli, Thomas ;
Dhadda, Amandeep ;
Myint, Arthur Sun .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (04) :356-367
[49]   Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203 [J].
Gerard, Jean-Pierre ;
Conroy, Thierry ;
Bonnetain, Franck ;
Bouche, Olivier ;
Chapet, Olivier ;
Closon-Dejardin, Marie-Therese ;
Untereiner, Michel ;
Leduc, Bernard ;
Francois, Eric ;
Maurel, Jean ;
Seitz, Jean-Francois ;
Buecher, Bruno ;
Mackiewicz, Remy ;
Ducreux, Michel ;
Bedenne, Laurent .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) :4620-4625
[50]   Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer [J].
Gerard, Jean-Pierre ;
Azria, David ;
Gourgou-Bourgade, Sophie ;
Martel-Lafay, Isabelle ;
Hennequin, Christophe ;
Etienne, Pierre-Luc ;
Vendrely, Veronique ;
Francois, Eric ;
de La Roche, Guy ;
Bouche, Olivier ;
Mirabel, Xavier ;
Denis, Bernard ;
Mineur, Laurent ;
Berdah, Jean-Francois ;
Mahe, Marc-Andre ;
Becouarn, Yves ;
Dupuis, Olivier ;
Lledo, Gerard ;
Seitz, Jean-Francois ;
Bedenne, Laurent ;
Juzyna, Beata ;
Conroy, Thierry .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) :4558-4565